Posted by Michael Wonder on 03 Jul 2017
FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy
3 July 2017 - Today, the U.S. FDA cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy.
This is the first cooling cap cleared by the agency for use in cancer patients with solid tumours.
“We are pleased to expand the use of this product for cancer patients with solid tumours to potentially minimise chemotherapy-induced hair loss,” said Binita Ashar, M.D., director, Division of Surgical Devices, in the FDA’s Center for Devices and Radiological Health. “Managing the side effects of chemotherapy is a critical component to overall health and quality of life.”
